VITASPRING BIOMEDICAL CO., LTD.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $96.4K | $45.4K |
| FY2022 | — | $1.6M | $107.2K |
| FY2023 | — | $-2.4M | $29.7K |
| FY2024 | — | $-3.4M | $0 |
| FY2025 | — | $-4.0M | $0 |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $96.4K | $45.4K |
| FY2022 | — | $1.6M | $107.2K |
| FY2023 | — | $-2.4M | $29.7K |
| FY2024 | — | $-3.4M | $0 |
| FY2025 | — | $-4.0M | $0 |